Sales of Patented Drugs to Be Excluded from “Innovation Box” Tax Relief Scheme

The “innovation box” tax break program, which is expected to be embraced in the FY2024 taxation reform, will be applied to income associated with the transfer of intellectual property assets or licensing, but not to the sales of patented medicines,...read more